Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells

Coronavirus disease (COVID-19), caused by SARS-CoV-2, has affected over 65 million individuals and killed over 1.5 million persons (December 8, 2020; www.who.int)(1). While fatality rates are higher among the elderly and those with underlying comorbidities(2), host factors that promote susceptibilit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:bioRxiv
Asıl Yazarlar: Spalinger, Marianne R., Hai, Rong, Li, Jiang, Santos, Alina N., Nordgren, Tara M., Tremblay, Michel L., Eckmann, Lars, Hanson, Elaine, Scharl, Michael, Wu, Xiwei, Boland, Brigid S., McCole, Declan F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cold Spring Harbor Laboratory 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7743066/
https://ncbi.nlm.nih.gov/pubmed/33330862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.12.09.416586
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller